GELS Stock Analysis: Buy, Sell, or Hold?
GELS - Gelteq Limited Ordinary Shares
$0.54
0.01 (2.82%)
▲
5d:
-9.69%
30d:
+4.92%
90d:
-22.44%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Get Alerted When GELS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GELS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GELS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GELS is currently trading at $0.54, which is considered slightly low relative to its 30-day fair value range of $0.46 to $1.01.
Technical Outlook: Technically, GELS is in a strong downtrend. The price is approaching resistance at $0.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GELS is in a strong downtrend. The price is approaching resistance at $0.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.46 -
$1.01
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- CAUTION: Recommendation downgraded due to -9.7% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.46 -
$1.01
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.41
Resistance Level
$0.55
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Revenue Growth (YoY)
48.9%
Share & Embed Analysis
Last updated: July 14, 2026 12:38 AM ET
Data refreshes hourly during market hours. Next update: 1:38 AM
Data refreshes hourly during market hours. Next update: 1:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GELS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$116 | 59 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$110 | 51 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 55 HOLD |
